ArticleBMJ open2017

Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma.

Katie Mills et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.